| 2025-06-25 | +41.4% | earnings | Seeking Alpha | Kewaunee Scientific Non-GAAP EPS of $1.95, revenue of $77.15M |
| 2025-06-26 | +38.7% | legal | SEC EDGAR | KEQU 8-K: 2.02 and (SEC Filing) |
| 2023-12-06 | +32.8% | earnings | Seeking Alpha | Kewaunee Scientific GAAP EPS of $0.93, revenue of $50.44M |
| 2023-12-06 | +32.8% | legal | SEC EDGAR | KEQU 8-K: 2.02 and (SEC Filing) |
| 2024-12-11 | +30.8% | earnings | Seeking Alpha | Kewaunee Scientific Non-GAAP EPS of $1.41, revenue of $47.76M |
| 2024-12-11 | +30.8% | legal | SEC EDGAR | KEQU 8-K: 2.02 and (SEC Filing) |
| 2025-09-11 | -23.3% | legal | SEC EDGAR | KEQU 8-K: 5.02, 5.03 (SEC Filing) |
| 2025-09-10 | -20.9% | earnings | Seeking Alpha | Kewaunee Scientific GAAP EPS of $1.04, revenue of $71.10M |
| 2025-09-10 | -20.9% | legal | SEC EDGAR | KEQU 8-K: 2.02 and (SEC Filing) |
| 2023-09-01 | +20.0% | legal | SEC EDGAR | KEQU 8-K: 2.02 and (SEC Filing) |
| 2024-06-26 | +19.4% | earnings | Seeking Alpha | Kewaunee Scientific Non-GAAP EPS of $1.55, revenue of $56.7M |
| 2024-06-26 | +19.4% | legal | SEC EDGAR | KEQU 8-K: 2.02 and (SEC Filing) |
| 2022-06-30 | +18.3% | earnings | Seeking Alpha | Kewaunee Scientific GAAP EPS of -$0.13, revenue of $49.72M |
| 2022-06-30 | +18.3% | legal | SEC EDGAR | KEQU 8-K: 2.02 and (SEC Filing) |
| 2023-08-31 | +13.8% | earnings | Seeking Alpha | Kewaunee Scientific GAAP EPS of $0.86, revenue of $49.84M |
| 2026-03-11 | -13.6% | earnings | MT Newswires | Kewaunee Scientific Fiscal Q3 Adjusted Earnings Fall, Revenue Rises |
| 2026-03-11 | -13.6% | news | PR Newswire | Kewaunee Scientific Reports Results for Third Quarter of Fiscal Year 2026 |
| 2026-03-11 | -13.6% | earnings | Seeking Alpha | Kewaunee Scientific GAAP EPS of $0.23, revenue of $69.4M |
| 2026-03-11 | -13.6% | legal | SEC EDGAR | KEQU 8-K: 2.02 and (SEC Filing) |
| 2026-03-11 | -13.6% | news | PR Newswire | Kewaunee Scientific Reports Results for Third Quarter of Fiscal Year 2026 - PR Newswire |
| 2024-11-01 | +9.8% | legal | SEC EDGAR | KEQU 8-K: 1.01, 2.01, 2.03, 7.01 (SEC Filing) |
| 2023-03-08 | +9.0% | earnings | Seeking Alpha | Kewaunee Scientific GAAP EPS of $0.25, revenue of $60.82M |
| 2023-03-08 | +9.0% | legal | SEC EDGAR | KEQU 8-K: 2.02 and (SEC Filing) |
| 2023-12-19 | +8.2% | news | Seeking Alpha | Kewaunee Scientific's Share Price Hasn't Caught Up To Results |
| 2022-09-08 | -7.3% | earnings | Seeking Alpha | Kewaunee Scientific GAAP EPS of -$0.27, revenue of $50.12M |
| 2022-09-08 | -7.3% | legal | SEC EDGAR | KEQU 8-K: 2.02 and (SEC Filing) |
| 2024-03-22 | +5.3% | legal | SEC EDGAR | KEQU 8-K: 5.02 and (SEC Filing) |
| 2026-02-25 | -5.2% | news | PR Newswire | Kewaunee Scientific to Report Results for Third Quarter Fiscal Year 2026 |
| 2026-02-25 | -5.2% | legal | SEC EDGAR | KEQU 8-K: 8.01 and (SEC Filing) |
| 2025-11-26 | -5.1% | legal | SEC EDGAR | KEQU 8-K: 8.01 and (SEC Filing) |
| 2025-09-12 | +4.7% | news | simplywall.st | Investors Will Want Kewaunee Scientific's (NASDAQ:KEQU) Growth In ROCE To Persist - simplywall.st |
| 2024-09-11 | -4.4% | earnings | Seeking Alpha | Kewaunee Scientific Non-GAAP EPS of $0.93, revenue of $48.39M |
| 2024-09-11 | -4.4% | legal | SEC EDGAR | KEQU 8-K: 2.02 and (SEC Filing) |
| 2022-03-30 | +4.2% | legal | SEC EDGAR | KEQU 8-K: 1.01, 2.01 (SEC Filing) |
| 2025-02-26 | +4.2% | legal | SEC EDGAR | KEQU 8-K: 8.01 and (SEC Filing) |
| 2026-04-16 | +4.1% | earnings | MarketBeat | Kewaunee Scientific (NASDAQ:KEQU) Stock Price Crosses Below 200-Day Moving Average - Time to Sell? - MarketBeat |
| 2023-11-15 | +4.1% | legal | SEC EDGAR | KEQU 8-K: 8.01 and (SEC Filing) |
| 2023-06-28 | +3.8% | earnings | Seeking Alpha | Kewaunee Scientific GAAP EPS of $0.34, revenue of $53.99M |
| 2023-06-28 | +3.8% | legal | SEC EDGAR | KEQU 8-K: 2.02 and (SEC Filing) |
| 2025-12-04 | +3.5% | legal | SEC EDGAR | KEQU 8-K: 1.01, 1.02, 2.03, 7.01 (SEC Filing) |
| 2024-06-23 | -3.2% | earnings | Seeking Alpha | Earnings week ahead: FedEx, Nike, Carnival, Micron, BlackBerry, Walgreens Boots, and more |
| 2025-06-29 | +3.1% | legal | Stock Titan | KEQU SEC Filings - Kewaunee Scienti 10-K, 10-Q, 8-K Forms - Stock Titan |
| 2025-06-28 | +3.1% | analyst | Seeking Alpha | Kewaunee Scientific: Huge Improvement In Operational Outlook (Upgrade To Buy) |
| 2025-03-12 | +3.0% | earnings | Seeking Alpha | Kewaunee Scientific Non-GAAP EPS of $1.09, revenue of $67.17M |
| 2025-03-12 | +3.0% | legal | SEC EDGAR | KEQU 8-K: 8.01 and (SEC Filing) |
| 2025-03-12 | +3.0% | legal | SEC EDGAR | KEQU 8-K: 2.02 and (SEC Filing) |
| 2023-03-07 | +3.0% | expansion | Seeking Alpha | Kewaunee Scientific gets contract for services to Indian Oil Corp |
| 2024-03-06 | -2.5% | earnings | Seeking Alpha | Kewaunee Scientific GAAP EPS of $0.85, revenue of $46.8M |
| 2024-03-06 | -2.5% | legal | SEC EDGAR | KEQU 8-K: 2.02 and (SEC Filing) |
| 2021-07-19 | +2.5% | news | Seeking Alpha | Kewaunee Scientific announces strategic alliance with Schneider Electric |
| 2024-06-12 | -2.5% | legal | SEC EDGAR | KEQU 8-K: 8.01 and (SEC Filing) |
| 2021-12-17 | +2.5% | earnings | Seeking Alpha | Kewaunee Scientific reports FQ2 results |
| 2021-12-17 | +2.5% | legal | SEC EDGAR | KEQU 8-K: 2.02 and (SEC Filing) |
| 2026-02-11 | +2.4% | analyst | Zacks | Top Analyst Reports for Eli Lilly, Marriott & Fortinet |
| 2025-08-27 | +2.4% | legal | SEC EDGAR | KEQU 8-K: 8.01 and (SEC Filing) |
| 2025-12-10 | -2.2% | earnings | Seeking Alpha | Kewaunee Scientific GAAP EPS of $0.82, revenue of $70.1M |
| 2025-12-10 | -2.2% | legal | SEC EDGAR | KEQU 8-K: 2.02 and (SEC Filing) |
| 2025-12-10 | -2.2% | legal | PR Newswire | Kewaunee Scientific Reports Results for Second Quarter of Fiscal Year 2026 - PR Newswire |
| 2021-12-23 | +2.2% | legal | SEC EDGAR | KEQU 8-K: 1.01 (SEC Filing) |
| 2021-07-09 | -2.2% | earnings | Seeking Alpha | Kewaunee Scientific reports FQ4 results |
| 2021-07-09 | -2.2% | legal | SEC EDGAR | KEQU 8-K: 2.02 and (SEC Filing) |
| 2021-11-15 | -2.1% | legal | SEC EDGAR | KEQU 8-K: 8.01 (SEC Filing) |
| 2022-05-04 | -1.8% | legal | SEC EDGAR | KEQU 8-K: 1.01 (SEC Filing) |
| 2022-12-19 | +1.8% | legal | SEC EDGAR | KEQU 8-K: 1.01 and 2.03 (SEC Filing) |
| 2026-04-14 | -1.8% | executive | PR Newswire | Kewaunee Scientific Corporation Appoints Jorge Santos as Vice President of International Sales, Laboratory Products Group |
| 2026-04-14 | -1.8% | news | Stock Titan | Kewaunee's global push brings in a Madrid-based sales veteran - Stock Titan |
| 2025-06-11 | -1.7% | legal | SEC EDGAR | KEQU 8-K: 8.01 and (SEC Filing) |
| 2025-05-14 | -1.6% | news | Intellectia AI | KEQU Stock: Price, Forecast, Financials & AI Analysis - Intellectia AI |
| 2026-02-12 | +1.4% | analyst | Zacks | The Zacks Analyst Blog Highlights Eli Lilly, Marriott International, Fortinet, GSI Technology and Kewaunee Scientific |
| 2023-08-25 | -1.3% | legal | SEC EDGAR | KEQU 8-K: 5.02, 5.07 (SEC Filing) |
| 2022-06-02 | -1.3% | legal | SEC EDGAR | KEQU 8-K: 1.01 (SEC Filing) |
| 2021-11-10 | +1.2% | legal | SEC EDGAR | KEQU 8-K: 8.01 (SEC Filing) |
| 2024-11-27 | -1.2% | legal | SEC EDGAR | KEQU 8-K: 8.01 and (SEC Filing) |
| 2024-09-24 | -1.1% | news | Seeking Alpha | The Excitement Around Kewaunee Scientific Corporation's Business Turnaround Is Dying Out |
| 2024-04-23 | +1.1% | legal | SEC EDGAR | KEQU 8-K: 8.01 (SEC Filing) |
| 2026-03-03 | -1.0% | news | PR Newswire | Kewaunee Scientific and Nu Aire Inc. to Attend analytica 2026 in Munich |
| 2026-03-03 | -1.0% | news | PR Newswire | Kewaunee Scientific and Nu Aire Inc. to Attend analytica 2026 in Munich - PR Newswire |
| 2021-08-13 | +1.0% | legal | SEC EDGAR | KEQU 8-K: 1.01 (SEC Filing) |
| 2022-05-27 | +0.8% | legal | SEC EDGAR | KEQU 8-K: 8.01 (SEC Filing) |
| 2024-12-16 | +0.7% | earnings | Seeking Alpha | Kewaunee Scientific: Growth Has Been Priced In After Q2 2025 Report |
| 2021-09-09 | -0.6% | earnings | Seeking Alpha | Kewaunee Scientific reports FQ1 results |
| 2021-09-09 | -0.6% | legal | SEC EDGAR | KEQU 8-K: 2.02 and (SEC Filing) |
| 2024-02-21 | +0.6% | legal | SEC EDGAR | KEQU 8-K: 8.01 and (SEC Filing) |
| 2023-12-08 | +0.5% | news | CNN | symbol__ Stock Quote Price and Forecast - CNN |
| 2024-08-28 | -0.5% | legal | SEC EDGAR | KEQU 8-K: 8.01 and (SEC Filing) |
| 2026-04-07 | -0.5% | earnings | MarketBeat | Kewaunee Scientific (NASDAQ:KEQU) Stock Crosses Below Two Hundred Day Moving Average - Time to Sell? - MarketBeat |
| 2026-04-02 | -0.5% | news | Stock Traders Daily | How Kewaunee Scientific Corporation (KEQU) Affects Rotational Strategy Timing - Stock Traders Daily |
| 2021-08-11 | -0.5% | expansion | Seeking Alpha | Kewaunee Scientific inks distribution partnership with NuAire |
| 2021-04-29 | -0.5% | legal | SEC EDGAR | KEQU 8-K: 1.01 (SEC Filing) |
| 2026-02-16 | +0.4% | news | Simply Wall St. | Kewaunee Scientific (NASDAQ:KEQU) Is Looking To Continue Growing Its Returns On Capital |
| 2022-12-08 | +0.4% | earnings | Seeking Alpha | Kewaunee Scientific GAAP EPS of -$0.09, revenue of $54.56M |
| 2022-12-08 | +0.4% | legal | SEC EDGAR | KEQU 8-K: 2.02 and (SEC Filing) |
| 2022-03-10 | +0.4% | earnings | Seeking Alpha | Kewaunee Scientific GAAP EPS of -$0.47, revenue of $40.63M |
| 2022-03-10 | +0.4% | expansion | Seeking Alpha | Kewaunee Scientific's Indian unit secures $17.3M contract by Dangote Oil |
| 2022-03-10 | +0.4% | legal | SEC EDGAR | KEQU 8-K: 2.02 and (SEC Filing) |
| 2026-03-17 | -0.1% | earnings | Zacks | Kewaunee Earnings Decline Y/Y in Q3 Despite Sales Growth |
| 2026-04-24 | — | news | Zacks | Top Stock Reports for Caterpillar, Texas Instruments & Boeing |
| 2026-04-24 | — | earnings | MarketBeat | Kewaunee Scientific (NASDAQ:KEQU) Stock Crosses Below Two Hundred Day Moving Average - Time to Sell? - MarketBeat |
| 2026-04-24 | — | news | MEXC Exchange | KEQU Price Today: Kewaunee Scientific Corp. Stock Price, Quote & Chart | MEXC - MEXC Exchange |